Dual therapy stent

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Dual Therapy Stent
Combo Dual Therapy Stent.png
The Combo Dual Therapy Stent (OrbusNeich)

A dual therapy stent is a coronary artery stent that combines the technology of a bioengineered stent and a drug eluting stent to both accelerate endothelial coverage (healing of the vessel) and to block cell proliferation, thereby reducing the risk of restenosis.[1]

The Combo Dual Therapy Stent (OrbusNeich) is the only dual therapy stent available today. It combines the Genous endothelial progenitor cell capture technology with an antiproliferative, biodegradable sirolimus drug elution.[2] The Combo Stent has received CE Mark approval[3] in Europe and was shown to be as effective as a paclitaxel-eluting stent in controlling neointimal hyperplasia.[4]


External links[edit]